Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group (Q29619344)
Jump to navigation
Jump to search
scientific article (publication date: 20 May 2007)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group |
scientific article (publication date: 20 May 2007) |
Statements
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group (English)
Moore MJ
Goldstein D
Hamm J
Figer A
Hecht JR
Gallinger S
Au HJ
Murawa P
Walde D
Wolff RA
Campos D
Lim R
Ding K
Clark G
Voskoglou-Nomikos T
Ptasynski M
Parulekar W
20 May 2007
25
1960-6
15